In humans and mice, a negative side effect of PPARα activation in muscle is in rare cases (<1%) muscle weakness and pain (myopathy) or very seldom breakdown of muscle (rhabdomyolysis) [126–129]. This evidence concerns the gene PPARA and myopathy.